Detailed information for compound 174516

Basic information

Technical information
  • TDR Targets ID: 174516
  • Name: 9-fluoro-5-(4-methoxyphenyl)-2,2,4-trimethyl- 1,5-dihydrochromeno[3,4-f]quinoline
  • MW: 401.473 | Formula: C26H24FNO2
  • H donors: 1 H acceptors: 0 LogP: 5.71 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)C1Oc2ccc(cc2c2c1c1C(=CC(Nc1cc2)(C)C)C)F
  • InChi: 1S/C26H24FNO2/c1-15-14-26(2,3)28-21-11-10-19-20-13-17(27)7-12-22(20)30-25(24(19)23(15)21)16-5-8-18(29-4)9-6-16/h5-14,25,28H,1-4H3
  • InChiKey: KVTIALKVENTGTL-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 9-fluoro-5-(4-methoxyphenyl)-2,2,4-trimethyl-1,5-dihydro[1]benzopyrano[3,4-f]quinoline

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens progesterone receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis high affinity choline transporter 1 0.1786 0.2542 0.2542
Schistosoma mansoni sodium/solute symporter 0.1786 0.2542 0.2542
Echinococcus multilocularis sodium coupled monocarboxylate transporter 1 0.1786 0.2542 0.2542
Echinococcus granulosus high affinity choline transporter 1 0.1786 0.2542 0.2542
Toxoplasma gondii transporter, solute:sodium symporter (SSS) family protein 0.1786 0.2542 0.5
Echinococcus multilocularis sodium:glucose cotransporter 2 0.6998 1 1
Echinococcus granulosus solute carrier family 5 0.6998 1 1
Echinococcus multilocularis solute carrier family 5 0.6998 1 1
Echinococcus granulosus sodium:glucose cotransporter 2 0.6998 1 1
Schistosoma mansoni inositol transporter 0.6998 1 1
Loa Loa (eye worm) hypothetical protein 0.1786 0.2542 1
Loa Loa (eye worm) hypothetical protein 0.1786 0.2542 1
Brugia malayi Sodium:solute symporter family protein 0.1786 0.2542 1
Schistosoma mansoni inositol transporter 0.6998 1 1
Echinococcus granulosus sodium coupled monocarboxylate transporter 1 0.1786 0.2542 0.2542
Echinococcus granulosus sodium:myo inositol cotransporter 0.6998 1 1
Echinococcus multilocularis sodium:myo inositol cotransporter 0.6998 1 1
Brugia malayi GH02984p 0.1786 0.2542 1
Schistosoma mansoni high-affinity choline transporter 0.1786 0.2542 0.2542
Onchocerca volvulus 0.1786 0.2542 1

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) = 270 nM Agonistic activity was measured for modulation of hPR-B (human progesterone receptor) in cotransfected CV-1 cells. ChEMBL. 9464361
EC50 (functional) = 270 nM Agonistic activity was measured for modulation of hPR-B (human progesterone receptor) in cotransfected CV-1 cells. ChEMBL. 9464361
Efficacy (functional) = 77 % Agonistic activity of the compound towards hPR-B (human progesterone receptor) in terms of efficacy expressed as percent relative to progesterone 100%. ChEMBL. 9464361
Efficacy (functional) = 77 % Agonistic activity of the compound towards hPR-B (human progesterone receptor) in terms of efficacy expressed as percent relative to progesterone 100%. ChEMBL. 9464361
Ki (binding) = 2.7 nM The binding affinity measured using baculovirus-expressed hPR-A in sf21 cells. ChEMBL. 9464361
Ki (binding) = 2.7 nM The binding affinity measured using baculovirus-expressed hPR-A in sf21 cells. ChEMBL. 9464361

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.